Aurobindo Pharma

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE406A01037
NSEID: AUROPHARMA
BSEID: 524804

INR

1,095.40

37.45 (3.54%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.81 lacs

{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,095.40",
    "chg": 37.45,
    "chgp": "3.54%",
    "dir": 1,
    "prev_price": "1,057.95",
    "mcapval": "64,183.72 Cr",
    "mcap": "Large Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE406A01037",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:09 AM",
    "bse_nse_vol": "8.81 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Surge in Aurobindo Pharma Call Options: 10,901 Contracts at Rs 1300 Strike Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-10901-call-contracts-at-rs-1300-strike-price-1700513",
        "imagepath": "",
        "date": "2025-04-03 15:00:03",
        "description": "Aurobindo Pharma Ltd. has emerged as one of the most active stocks in the pharmaceuticals and drugs sector today, with significant trading activity in its call options. The stock, trading under the ticker AUROPHARMA, saw 10,901 contracts traded for call options set to expire on April 24, 2025, at a strike price of Rs 1300. This activity generated a turnover of approximately Rs 1156.05 lakhs, while the open interest stood at 1,842 contracts, indicating a robust interest in this option.\n\nIn terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and reached an intraday high of Rs 1267.3, reflecting a 9.45% increase. Despite this positive movement, the stock underperformed its sector by 0.25%, although it has shown a consecutive gain over the past two days, accumulating a total return of 3.87%. The stock's weighted average price suggests that more volume was traded closer to its low pr..."
      },
      {
        "title": "Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-33-48-surge-in-open-interest-amid-increased-trading-activity-1699360",
        "imagepath": "",
        "date": "2025-04-03 14:00:04",
        "description": "Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 44,346 contracts, a notable rise from the previous open interest of 33,224 contracts, marking a change of 11,122 contracts or 33.48%. The trading volume for the day reached 99,412 contracts, indicating robust participation in the market.\n\nIn terms of price performance, Aurobindo Pharma opened with a gain of 6.15% and has shown a consecutive gain over the last two days, accumulating a total return of 4.28% during this period. The stock reached an intraday high of Rs 1,267.3, reflecting a 9.45% increase at its peak. The weighted average price suggests that more volume was traded closer to the lower price levels.\n\nAurobindo Pharma operates within the Pharmaceuticals & Drugs sector, which has seen a gain of 2.18% today. The stock's liquidity remai..."
      },
      {
        "title": "Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-31-85-surge-in-open-interest-amid-increased-market-activity-1698284",
        "imagepath": "",
        "date": "2025-04-03 13:00:05",
        "description": "Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 43,805 contracts, up from the previous 33,224 contracts, marking a change of 10,581 contracts or a 31.85% increase. The trading volume for the day reached 91,998 contracts, indicating robust market engagement.\n\nIn terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and has recorded a consecutive gain over the past two days, accumulating a total return of 4.46%. The stock reached an intraday high of Rs 1,267.3, reflecting a 9.45% increase during the trading session. The weighted average price suggests that more volume was traded closer to the lower price levels.\n\nAurobindo Pharma operates within the Pharmaceuticals & Drugs sector, which has seen a gain of 2.23% today. The stock's liquidity remains strong, with..."
      },
      {
        "title": "Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-31-85-surge-in-open-interest-amid-increased-trading-activity-1696961",
        "imagepath": "",
        "date": "2025-04-03 12:00:04",
        "description": "Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 43,805 contracts, up from the previous 33,224 contracts, marking a change of 10,581 contracts or a 31.85% increase. The trading volume for the day reached 91,998 contracts, indicating robust market engagement.\n\nIn terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and reached an intraday high of Rs 1,267.3, reflecting a 9.45% increase. Despite this positive movement, the stock has underperformed its sector by 0.41%, although it has shown a consecutive gain over the last two days, yielding a total return of 4.21% during this period.\n\nThe stock's weighted average price suggests that more volume was traded closer to its low price, while it remains above its 5-day, 20-day, and 50-day moving averages, but below t..."
      },
      {
        "title": "Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-21-34-surge-in-open-interest-to-40314-contracts-1695888",
        "imagepath": "",
        "date": "2025-04-03 11:00:04",
        "description": "Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the pharmaceuticals and drugs sector. The latest open interest stands at 40,314 contracts, up from the previous 33,224, marking a change of 7,090 contracts or a 21.34% increase. The trading volume for the day reached 50,536 contracts, indicating robust market engagement.\n\nIn terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and has outperformed its sector by 0.64%. The stock has shown consecutive gains over the last two days, accumulating a total return of 5.26% during this period. It reached an intraday high of Rs 1,267.3, reflecting a 9.45% increase at its peak.\n\nThe stock's weighted average price suggests that more volume was traded closer to its low price, while it remains above its 5-day, 20-day, and 50-day moving averages, although it is below th..."
      },
      {
        "title": "Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-21-34-surge-in-open-interest-amid-increased-trading-activity-1694544",
        "imagepath": "",
        "date": "2025-04-03 10:00:04",
        "description": "Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 40,314 contracts, up from the previous figure of 33,224, marking a change of 7,090 contracts or a 21.34% increase. The trading volume for the day reached 50,536 contracts, indicating robust market engagement.\n\nIn terms of price performance, Aurobindo Pharma has outperformed its sector by 2.65%, with the stock gaining 8.79% over the last two days. Today, it opened with a notable gain of 6.15%, reaching an intraday high of Rs 1,267.3, which represents a 9.45% increase. The stock's weighted average price suggests that more volume was traded closer to its low price, while it remains above its 5-day, 20-day, 50-day, and 100-day moving averages, although it is below the 200-day moving average.\n\nThe pharmaceuticals and drugs sector has also sho..."
      },
      {
        "title": "Aurobindo Pharma Shows Resilience Amid Market Volatility and Sector Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-stock-rises-5-77-outperforming-pharmaceuticals-sector-on-april-3-2025-1693270",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/AurobindoPharma_priceRelatedfactors_882923.png",
        "date": "2025-04-03 09:30:22",
        "description": "Aurobindo Pharma has demonstrated notable performance, gaining 5.77% on April 3, 2025, and outperforming its sector. The stock has shown high volatility and is currently above several moving averages. Despite a year-to-date decline, it has significantly increased over the past three years compared to the broader market."
      },
      {
        "title": "Aurobindo Pharma Faces Short-Term Challenges Amidst Long-Term Growth Potential",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-stock-declines-3-19-amid-broader-market-downturn-1609597",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AurobindoPharma_priceRelatedfactors_814201.png",
        "date": "2025-03-26 15:45:17",
        "description": "Aurobindo Pharma's stock has declined over the past two days, losing a total of 4.38%. While it has outperformed the Sensex over the past month, its year-to-date performance remains negative. The stock shows mixed short-term performance relative to longer-term trends, with significant growth over the past five years."
      },
      {
        "title": "Aurobindo Pharma Sees Significant Open Interest Surge Amidst Price Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-13-68-surge-in-open-interest-amid-increased-futures-activity-2-1608701",
        "imagepath": "",
        "date": "2025-03-26 15:00:06",
        "description": "Aurobindo Pharma Ltd. has experienced a notable increase in open interest today, with the latest open interest (OI) recorded at 37,901, up from the previous OI of 33,341. This represents a change of 4,560, or a 13.68% increase. The trading volume for the stock reached 23,467, contributing to a futures value of approximately Rs 66,428 lakhs and an options value of around Rs 86,024 crores, bringing the total value to Rs 67,158 lakhs.\n\nIn terms of price performance, Aurobindo Pharma has underperformed its sector by 2.08%, with the stock declining by 4.14% over the last two days. Today, it touched an intraday low of Rs 1,159.05, reflecting a decrease of 3%. The weighted average price indicates that more volume was traded closer to this low price. While the stock remains above its 20-day and 50-day moving averages, it is currently below its 5-day, 100-day, and 200-day moving averages.\n\nInvestor participation app..."
      }
    ],
    "total": 128,
    "sid": "164981",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "09-Apr-2025",
      "details": "Submission of press release being issued by the Company.",
      "source": "BSE"
    },
    {
      "caption": "Curateq Biologics Received Marketing Authorization For Dyrupeg™ A Pegylated Filgrastim Biosimilar",
      "datetime": "05-Apr-2025",
      "details": "Intimation of receipt of Marketing authorisation by Curateq Biologics s.r.o a wholly owned step down subsidiary of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Apr-2025",
      "details": "Submission of Certificate under regulation 74 (5) of SEBI (DP) Regulations for the Quarter ended March 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>150%</strong> dividend, ex-date: 20 Feb 24",
          "dt": "2024-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Surge in Aurobindo Pharma Call Options: 10,901 Contracts at Rs 1300 Strike Price

2025-04-03 15:00:03

Aurobindo Pharma Ltd. has emerged as one of the most active stocks in the pharmaceuticals and drugs sector today, with significant trading activity in its call options. The stock, trading under the ticker AUROPHARMA, saw 10,901 contracts traded for call options set to expire on April 24, 2025, at a strike price of Rs 1300. This activity generated a turnover of approximately Rs 1156.05 lakhs, while the open interest stood at 1,842 contracts, indicating a robust interest in this option. In terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and reached an intraday high of Rs 1267.3, reflecting a 9.45% increase. Despite this positive movement, the stock underperformed its sector by 0.25%, although it has shown a consecutive gain over the past two days, accumulating a total return of 3.87%. The stock's weighted average price suggests that more volume was traded closer to its low pr...

Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity

2025-04-03 14:00:04

Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 44,346 contracts, a notable rise from the previous open interest of 33,224 contracts, marking a change of 11,122 contracts or 33.48%. The trading volume for the day reached 99,412 contracts, indicating robust participation in the market. In terms of price performance, Aurobindo Pharma opened with a gain of 6.15% and has shown a consecutive gain over the last two days, accumulating a total return of 4.28% during this period. The stock reached an intraday high of Rs 1,267.3, reflecting a 9.45% increase at its peak. The weighted average price suggests that more volume was traded closer to the lower price levels. Aurobindo Pharma operates within the Pharmaceuticals & Drugs sector, which has seen a gain of 2.18% today. The stock's liquidity remai...

Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity

2025-04-03 13:00:05

Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 43,805 contracts, up from the previous 33,224 contracts, marking a change of 10,581 contracts or a 31.85% increase. The trading volume for the day reached 91,998 contracts, indicating robust market engagement. In terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and has recorded a consecutive gain over the past two days, accumulating a total return of 4.46%. The stock reached an intraday high of Rs 1,267.3, reflecting a 9.45% increase during the trading session. The weighted average price suggests that more volume was traded closer to the lower price levels. Aurobindo Pharma operates within the Pharmaceuticals & Drugs sector, which has seen a gain of 2.23% today. The stock's liquidity remains strong, with...

Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity

2025-04-03 12:00:04

Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 43,805 contracts, up from the previous 33,224 contracts, marking a change of 10,581 contracts or a 31.85% increase. The trading volume for the day reached 91,998 contracts, indicating robust market engagement. In terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and reached an intraday high of Rs 1,267.3, reflecting a 9.45% increase. Despite this positive movement, the stock has underperformed its sector by 0.41%, although it has shown a consecutive gain over the last two days, yielding a total return of 4.21% during this period. The stock's weighted average price suggests that more volume was traded closer to its low price, while it remains above its 5-day, 20-day, and 50-day moving averages, but below t...

Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity

2025-04-03 11:00:04

Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the pharmaceuticals and drugs sector. The latest open interest stands at 40,314 contracts, up from the previous 33,224, marking a change of 7,090 contracts or a 21.34% increase. The trading volume for the day reached 50,536 contracts, indicating robust market engagement. In terms of price performance, Aurobindo Pharma opened with a notable gain of 6.15% and has outperformed its sector by 0.64%. The stock has shown consecutive gains over the last two days, accumulating a total return of 5.26% during this period. It reached an intraday high of Rs 1,267.3, reflecting a 9.45% increase at its peak. The stock's weighted average price suggests that more volume was traded closer to its low price, while it remains above its 5-day, 20-day, and 50-day moving averages, although it is below th...

Aurobindo Pharma Sees Surge in Open Interest Amid Increased Trading Activity

2025-04-03 10:00:04

Aurobindo Pharma Ltd. has experienced a significant increase in open interest today, reflecting heightened trading activity in the stock. The latest open interest stands at 40,314 contracts, up from the previous figure of 33,224, marking a change of 7,090 contracts or a 21.34% increase. The trading volume for the day reached 50,536 contracts, indicating robust market engagement. In terms of price performance, Aurobindo Pharma has outperformed its sector by 2.65%, with the stock gaining 8.79% over the last two days. Today, it opened with a notable gain of 6.15%, reaching an intraday high of Rs 1,267.3, which represents a 9.45% increase. The stock's weighted average price suggests that more volume was traded closer to its low price, while it remains above its 5-day, 20-day, 50-day, and 100-day moving averages, although it is below the 200-day moving average. The pharmaceuticals and drugs sector has also sho...

Aurobindo Pharma Shows Resilience Amid Market Volatility and Sector Gains

2025-04-03 09:30:22

Aurobindo Pharma has demonstrated notable performance, gaining 5.77% on April 3, 2025, and outperforming its sector. The stock has shown high volatility and is currently above several moving averages. Despite a year-to-date decline, it has significantly increased over the past three years compared to the broader market.

Aurobindo Pharma Faces Short-Term Challenges Amidst Long-Term Growth Potential

2025-03-26 15:45:17

Aurobindo Pharma's stock has declined over the past two days, losing a total of 4.38%. While it has outperformed the Sensex over the past month, its year-to-date performance remains negative. The stock shows mixed short-term performance relative to longer-term trends, with significant growth over the past five years.

Aurobindo Pharma Sees Significant Open Interest Surge Amidst Price Challenges

2025-03-26 15:00:06

Aurobindo Pharma Ltd. has experienced a notable increase in open interest today, with the latest open interest (OI) recorded at 37,901, up from the previous OI of 33,341. This represents a change of 4,560, or a 13.68% increase. The trading volume for the stock reached 23,467, contributing to a futures value of approximately Rs 66,428 lakhs and an options value of around Rs 86,024 crores, bringing the total value to Rs 67,158 lakhs. In terms of price performance, Aurobindo Pharma has underperformed its sector by 2.08%, with the stock declining by 4.14% over the last two days. Today, it touched an intraday low of Rs 1,159.05, reflecting a decrease of 3%. The weighted average price indicates that more volume was traded closer to this low price. While the stock remains above its 20-day and 50-day moving averages, it is currently below its 5-day, 100-day, and 200-day moving averages. Investor participation app...

View All News